60
Participants
Start Date
August 31, 2014
Primary Completion Date
January 2, 2019
Study Completion Date
January 2, 2019
Sunitinib
"Starting dose: 50 mg by mouth daily given for 2 weeks on followed by 1 week off. 1 cycle is 6 weeks."
Questionnaire
Questionnaire completion on Day 1 of Cycle 1, and on Day 35 of Cycles 2, 4, and 6.
Lineberger Cancer Center, Chapel Hill
Cleveland Clinic Taussig Cancer Institute, Cleveland
University of Texas MD Anderson Cancer Center, Houston
Stanford University Medical Center, Stanford
Fox Chase Cancer Center, Philadelphia
Collaborators (1)
Pfizer
INDUSTRY
M.D. Anderson Cancer Center
OTHER